Financials Edenred SE

Equities

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-01-21 am EST			After hours 02:36:45 pm
19.00 ^EUR	+10.47%		19.05	+0.31%

12:46pm	European shares end flat as Trump tones down Greenland rhetoric	RE
11:55am	European Markets Remain Fragile: CAC 40 Barely Ends Losing Streak

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	1,465	1,627	2,031	2,514	2,856	2,956	2,948	3,163
Change	-	11.06%	24.83%	23.78%	13.6%	3.51%	-0.27%	7.28%
EBITDA ¹	580	670	836	1,094	1,265	1,342	1,264	1,373
Change	-	15.52%	24.78%	30.86%	15.63%	6.11%	-5.8%	8.57%
EBIT ¹	455	538	687	901	1,040	1,084	1,002	1,095
Change	-	18.24%	27.7%	31.15%	15.43%	4.24%	-7.57%	9.28%
Interest Paid ¹	-37	-19	-54	-172	-213	-229.9	-222.6	-221.1
Earnings before Tax (EBT) ¹	390	494	605	534	799	838.2	776	876.3
Change	-	26.67%	22.47%	-11.74%	49.63%	4.91%	-7.42%	12.92%
Net income ¹	238	313	386	267	507	532.1	472.2	519.2
Change	-	31.51%	23.32%	-30.83%	89.89%	4.94%	-11.25%	9.95%
Announcement Date	3/2/21	2/22/22	2/21/23	2/27/24	2/18/25	-	-	-

¹EUR in Million

Estimates

Fiscal Period: December	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2022 Q1	2022 Q2	2022 Q4	2023 Q1	2023 Q2	2023 Q4	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4
Net sales ¹	357	412	373	384	405	439	482	603	557	606	717	710	682	779	724	727	726	782
Change	-	15.41%	-9.47%	2.95%	5.47%	8.4%	9.79%	25.1%	-7.63%	8.8%	18.32%	-0.98%	-3.94%	14.22%	-7.06%	0.41%	-0.14%	7.71%
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBIT	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Charge d'intérêts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings before Tax (EBT)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Announcement Date	10/22/20	3/2/21	4/22/21	7/27/21	10/21/21	4/21/22	7/26/22	2/21/23	4/20/23	7/25/23	2/27/24	7/23/24	10/24/24	2/18/25	4/23/25	7/23/25	10/21/25	-

¹EUR in Million

Estimates

Fiscal Period: December	2021 S1	2021 S2	2022 S1	2022 S2	2023 S1	2023 S2	2024 S1	2024 S2	2025 S1	2025 S2	2026 S1	2026 S2
Net sales ¹	757	870	922	1,109	1,163	1,351	1,395	1,461	1,451	1,509	1,505	1,645
Change	-	14.93%	5.98%	20.28%	4.87%	16.17%	3.26%	4.73%	-0.68%	4.01%	-0.28%	9.29%
EBITDA ¹	295	-	365	471	483	611	597	668	654	705	-	-
Change	-	-	-	29.04%	2.55%	26.5%	-2.29%	11.89%	-2.1%	7.8%	-	-
EBIT ¹	232	-	295	392	399	-	488	552	522	588	-	-
Change	-	-	-	32.88%	1.79%	-	-	13.11%	-5.43%	12.64%	-	-
Charge d'intérêts ¹	-	-	-17	-37	-	-	-98	-115	-113	-132	-	-
Earnings before Tax (EBT)	-	-	270	-	-	-	377	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-
Net income ¹	-	-	170	-	202	-	235	272	235	301	-	-
Change	-	-	-	-	-	-	-	15.74%	-13.6%	28.09%	-	-
Announcement Date	7/27/21	2/22/22	7/26/22	2/21/23	7/25/23	2/27/24	7/23/24	2/18/25	7/23/25	-	-	-

¹EUR in Million

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt ¹	1,115	816	307	1,100	1,806	1,637	1,330	1,031
Change	-	-26.82%	-62.38%	258.31%	64.18%	-9.36%	-18.75%	-22.48%
Announcement Date	3/2/21	2/22/22	2/21/23	2/27/24	2/18/25	-	-	-

¹EUR in Million

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
CAPEX ¹	104	114	151	190	217	214.6	215.2	231.8
Change	-	9.62%	32.46%	25.83%	14.21%	-1.1%	0.25%	7.76%
Free Cash Flow (FCF) ¹	614	490	881	905	832	893	899.6	855.9
Change	-	-20.2%	79.8%	2.72%	-8.07%	7.34%	0.73%	-4.86%
Announcement Date	3/2/21	2/22/22	2/21/23	2/27/24	2/18/25	-	-	-

¹EUR in Million

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	39.59%	41.18%	41.16%	43.52%	44.29%	45.41%	42.89%	43.4%
EBIT Margin (%)	31.06%	33.07%	33.83%	35.84%	36.41%	36.67%	33.99%	34.62%
EBT Margin (%)	26.62%	30.36%	29.79%	21.24%	27.98%	28.36%	26.32%	27.7%
Net margin (%)	16.25%	19.24%	19.01%	10.62%	17.75%	18%	16.02%	16.42%
FCF margin (%)	41.91%	30.12%	43.38%	36%	29.13%	30.21%	30.51%	27.06%
FCF / Net Income (%)	257.98%	156.55%	228.24%	338.95%	164.1%	167.84%	190.5%	164.85%
Profitability
ROA	2.6%	3.17%	3.59%	2.18%	3.82%	3.96%	3.58%	3.99%
ROE	-19.65%	-	-	-	-	-	-	-
Financial Health
Leverage (Debt/EBITDA)	1.92x	1.22x	0.37x	1.01x	1.43x	1.22x	1.05x	0.75x
Debt / Free cash flow	1.82x	1.67x	0.35x	1.22x	2.17x	1.83x	1.48x	1.2x
Capital Intensity
CAPEX / Current Assets (%)	7.1%	7.01%	7.43%	7.56%	7.6%	7.26%	7.3%	7.33%
CAPEX / EBITDA (%)	17.93%	17.01%	18.06%	17.37%	17.15%	15.99%	17.02%	16.89%
CAPEX / FCF (%)	16.94%	23.27%	17.14%	20.99%	26.08%	24.03%	23.92%	27.09%
Items per share
Cash flow per share ¹	2.926	2.296	3.832	4.14	4.152	4.013	3.585	4.037
Change	-	-21.51%	66.88%	8.04%	0.28%	-3.35%	-10.65%	12.6%
Dividend per Share ¹	0.75	0.9	1	1.1	1.21	1.314	1.354	1.484
Change	-	20%	11.11%	10%	10%	8.61%	3.03%	9.59%
Book Value Per Share ¹	-5.002	-3.496	-2.883	-2.727	-3.782	-3.562	-3.221	-2.405
Change	-	30.1%	17.53%	5.41%	-38.68%	5.84%	9.56%	25.32%
EPS ¹	0.97	1.19	1.46	1.01	2.01	2.141	1.979	2.252
Change	-	22.68%	22.69%	-30.82%	99.01%	6.52%	-7.57%	13.81%
Nbr of stocks (in thousands)	245,817	249,135	249,207	249,257	241,974	240,087	240,087	240,087
Announcement Date	3/2/21	2/22/22	2/21/23	2/27/24	2/18/25	-	-	-